Cargando…
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus
Currently, the expansion of the novel human respiratory coronavirus (known as SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], COVID-2019 [coronavirus disease 2019], or 2019-nCoV [2019 novel coronavirus]) has stressed the need for therapeutic alternatives to alleviate and stop this new...
Autor principal: | Martinez, Miguel Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179632/ https://www.ncbi.nlm.nih.gov/pubmed/32152082 http://dx.doi.org/10.1128/AAC.00399-20 |
Ejemplares similares
-
Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options
por: Khan, Suliman, et al.
Publicado: (2020) -
Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects
por: Loinaz-Segurola, Carmelo, et al.
Publicado: (2021) -
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions
por: Jogalekar, Manasi P, et al.
Publicado: (2020) -
Extracorporeal membrane oxygenation and inhaled sedation in coronavirus disease 2019-related acute respiratory distress syndrome
por: Bellgardt, Martin, et al.
Publicado: (2021) -
Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury
por: Han, Mei-Wen, et al.
Publicado: (2021)